People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)